Metastatic Bone Disease With Pathologic or Impending Pathologic Fractures: Resolve, Refer, or Collaborate

Area of Science:

• Orthopaedic Surgery
• Oncology
• Bone Metastasis Management

Background:

• Pathologic fractures from metastatic disease are common in orthopaedic practice.
• Access to orthopaedic oncologists may be limited, necessitating management by general orthopaedic surgeons.
• Timely intervention is crucial to avoid patient delays and optimize outcomes.

Purpose of the Study:

• To equip non-oncologic orthopaedic surgeons with essential principles for managing pathologic fractures.
• To differentiate metastatic fractures from primary bone sarcomas.
• To outline surgical decision-making and recognize unique challenges.

Main Methods:

• Review of clinical and surgical principles for pathologic fracture management.
• Discussion of diagnostic considerations, including differentiating metastatic disease from primary bone sarcoma.
• Analysis of surgical challenges and complication risks associated with pathologic fractures.
• Examination of specific anatomic sites (pelvis, acetabulum) and upper extremity/shoulder management.

Main Results:

• General orthopaedic surgeons can manage many pathologic fractures effectively.
• Key considerations include accurate diagnosis, appropriate treatment modality selection (surgical vs. non-surgical), and awareness of surgical complexities.
• Complex cases may benefit from orthopaedic oncologist consultation or collaborative care.

Conclusions:

• All orthopaedic surgeons need foundational knowledge in pathologic fracture management.
• Understanding diagnostic nuances and surgical challenges is imperative.
• Collaboration and appropriate referral pathways optimize patient care for metastatic bone disease.